Status:
ACTIVE_NOT_RECRUITING
Weight Loss Clinical Decision Support
Lead Sponsor:
HealthPartners Institute
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes Mellitus, Type 2
Obesity
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Despite steady increases in obesity prevalence, the more than 12 million obese U.S. adults with type 2 diabetes (T2DM) and severe obesity encounter a number of barriers to adopting effective surgical ...
Detailed Description
Obesity has been steadily increasing in prevalence and now affects more than 4 in 10 U.S. adults, leading to many adverse health outcomes including myocardial infarction, stroke, type 2 diabetes (T2DM...
Eligibility Criteria
Inclusion
- Adults (age 18-75 years at index clinical encounter)
- Existing diagnosis of T2DM
- BMI ≥35 kg/m2 at index clinical encounter
- Have an index clinical encounter with a PCC (family practice or general internal medicine physician, nurse practitioner, or physician assistant) at a randomized study clinic during a 12-month accrual period
Exclusion
- Prior MBS
- Patients diagnosed with cancer (except non-melanoma skin cancer), dementia, and/or cirrhosis.
- Pregnant or breastfeeding.
- In long-term care, palliative care, or hospice care.
Key Trial Info
Start Date :
April 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
10120 Patients enrolled
Trial Details
Trial ID
NCT05198765
Start Date
April 19 2023
End Date
April 30 2026
Last Update
November 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HealthPartners Medical Group
Minneapolis, Minnesota, United States, 55440